Vasculitis Global Clinical Trials Review, H1, 2015

Vasculitis Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2668CTIDB
  • |
  • Pages: 81
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Vasculitis Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Vasculitis Global Clinical Trials Review, H1, 2015" provides data on the Vasculitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vasculitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Vasculitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Vasculitis 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Vasculitis to Cardiovascular Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Vasculitis to Cardiovascular Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Vasculitis 25

Subjects Recruited Over a Period of Time 28

Clinical Trials by Sponsor Type 29

Prominent Sponsors 30

Top Companies Participating in Vasculitis Therapeutics Clinical Trials 31

Prominent Drugs 33

Latest Clinical Trials News on Vasculitis 34

Apr 21, 2015: Kineta, University of Groningen Present New, Positive Data for Dalazatide in ANCA Vasculitis, an Orphan Disease 34

Clinical Trial Profiles 35

Clinical Trial Overview of Top Companies 35

F. Hoffmann-La Roche Ltd. 35

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 35

Novartis AG 37

Clinical Trial Overview of Novartis AG 37

Zenyaku Kogyo Co., Ltd. 38

Clinical Trial Overview of Zenyaku Kogyo Co., Ltd. 38

Pluristem Therapeutics Inc. 39

Clinical Trial Overview of Pluristem Therapeutics Inc. 39

GlaxoSmithKline plc 40

Clinical Trial Overview of GlaxoSmithKline plc 40

ChemoCentryx, Inc. 41

Clinical Trial Overview of ChemoCentryx, Inc. 41

AnGes MG, Inc. 42

Clinical Trial Overview of AnGes MG, Inc. 42

Actelion Ltd 43

Clinical Trial Overview of Actelion Ltd 43

AbbVie Inc. 44

Clinical Trial Overview of AbbVie Inc. 44

Clinical Trial Overview of Top Institutes / Government 45

Assistance Publique-Hopitaux de Paris 45

Clinical Trial Overview of Assistance Publique-Hopitaux de Paris 45

The National Institute of Allergy and Infectious Diseases 46

Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 46

Cambridge University Hospitals NHS Foundation Trust 47

Clinical Trial Overview of Cambridge University Hospitals NHS Foundation Trust 47

Saitama Medical University 48

Clinical Trial Overview of Saitama Medical University 48

Ministry of Health, Labour and Welfare, Japan 49

Clinical Trial Overview of Ministry of Health, Labour and Welfare, Japan 49

Nanjing University 50

Clinical Trial Overview of Nanjing University 50

Osaka University 51

Clinical Trial Overview of Osaka University 51

Pitie-Salpetriere Hospital 52

Clinical Trial Overview of Pitie-Salpetriere Hospital 52

University Hospital, Toulouse 53

Clinical Trial Overview of University Hospital, Toulouse 53

University Medical Center Groningen 54

Clinical Trial Overview of University Medical Center Groningen 54

Five Key Clinical Profiles 55

Appendix 79

Abbreviations 79

Definitions 79

Research Methodology 80

Secondary Research 80

About GlobalData 81

Contact Us 81

Disclaimer 81

Source 81

List of Figures

Vasculitis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Vasculitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Vasculitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Vasculitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Vasculitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Vasculitis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Vasculitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Vasculitis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Vasculitis to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15

Vasculitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Vasculitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Vasculitis to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18

Vasculitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Vasculitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Vasculitis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Vasculitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Vasculitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Vasculitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Vasculitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Vasculitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29

Vasculitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Vasculitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Vasculitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

GlobalData Methodology 80

List of Tables

Vasculitis Therapeutics, Global, Clinical Trials by Region, 2015* 7

Vasculitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Vasculitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Vasculitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Vasculitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Vasculitis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Vasculitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Vasculitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Vasculitis to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15

Vasculitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Vasculitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Vasculitis to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18

Vasculitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Vasculitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Vasculitis Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Vasculitis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Vasculitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Vasculitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Vasculitis Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Vasculitis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Vasculitis Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Vasculitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Vasculitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29

Vasculitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Vasculitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32

Vasculitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 35

Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 37

Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zenyaku Kogyo Co., Ltd., 2015* 38

Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pluristem Therapeutics Inc., 2015* 39

Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 40

Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by ChemoCentryx, Inc., 2015* 41

Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by AnGes MG, Inc., 2015* 42

Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2015* 43

Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 44

Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique-Hopitaux de Paris, 2015* 45

Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 46

Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cambridge University Hospitals NHS Foundation Trust, 2015* 47

Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Saitama Medical University, 2015* 48

Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministry of Health, Labour and Welfare, Japan, 2015* 49

Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing University, 2015* 50

Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2015* 51

Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pitie-Salpetriere Hospital, 2015* 52

Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Toulouse, 2015* 53

Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2015* 54

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Vasculitis Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Vasculitis, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 161425
Site License
USD 5000 INR 322850
Corporate User License
USD 7500 INR 484275

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com